<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01080144</url>
  </required_header>
  <id_info>
    <org_study_id>09 156 02</org_study_id>
    <nct_id>NCT01080144</nct_id>
  </id_info>
  <brief_title>Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal Encephalopathy</brief_title>
  <official_title>A Pilot Study Aiming to Assess the Feasibility of Critical Flicker Frequency for the Diagnosis of Minimal Encephalopathy in Patients With Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All patients eligible for TIPS (Transjugular intrahepatic portosystemic shunt) procedure will
      be considered for inclusion. After written inform consent, psychometric tests in order to
      calculate the psychometric hepatic encephalopathy (PHES) score, the gold standard for the
      diagnosis of minimal encephalopathy and critical flicker frequency (CFF) will be performed
      before the TIPS procedure. After TIPS, patients will be followed during one year and the
      psychometric test and CFF will be performed every 3 months.

      30 patients will be included.

      The main endpoint is the success rate of CFF. The secondary end points are

        -  Correlation between CFF and PHES score

        -  Performance of CFF and PHES score to predict the occurrence of overt encephalopathy
           after TIPS procedure

        -  A sample collection during TIPS procedure is also performed for validation of biomarkers
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate of Critical Flicker Frequency (CFF) Procedure</measure>
    <time_frame>before TIPS and every 3 months till one year</time_frame>
    <description>number of patients in whom ten measurement will be available / 30 patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurrence of encephalopathy</measure>
    <time_frame>every 3 months till one year after TIPS procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Critical Flicker Frequency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Critical Flicker Frequency Procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Critical flicker frequency procedure</intervention_name>
    <description>After TIPS, patients will be followed during one year and the psychometric test and Critical flicker frequency procedure will be performed every 3 months</description>
    <arm_group_label>Critical Flicker Frequency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with cirrhosis in whom a TIPS is indicated

          -  patients have given their informed consent te be included

        Exclusion Criteria:

          -  minor

          -  pregnant women

          -  patients who cannot see the red color

          -  refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Bureau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr Christophe Bureau</name>
      <address>
        <city>Toulouse</city>
        <state>Hôpital Rangueil</state>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Berlioux P, Robic MA, Poirson H, Métivier S, Otal P, Barret C, Lopez F, Péron JM, Vinel JP, Bureau C. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology. 2014 Feb;59(2):622-9.</citation>
    <PMID>24620380</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2010</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cirrhosis</keyword>
  <keyword>TIPS (Transjugular intrahepatic portosystemic shunt)</keyword>
  <keyword>Encephalopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

